Related Experiment Video
Updated: May 25, 2026
07:29
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Host-tumor interactions in nasopharyngeal carcinomas
Claire Gourzones1, Clément Barjon, Pierre Busson
1Université Paris-Sud-11, CNRS-UMR 8126 and Institut de cancérologie Gustave Roussy, 39 rue Camille Desmoulins, F-94805 Villejuif, France.
Seminars in Cancer Biology
|January 18, 2012
Summary
Nasopharyngeal carcinoma (NPC) is a heterogeneous disease involving complex cellular interactions. Tumor products in patient blood may serve as biomarkers for assessing aggressiveness and monitoring treatment response.
Area of Science:
- Oncology
- Immunology
- Biochemistry
Background:
- Nasopharyngeal carcinoma (NPC) is a complex disease characterized by significant tumor cell heterogeneity and extensive infiltration by non-malignant leukocytes.
- Malignant epithelial cells in NPC produce inflammatory cytokines, suggesting a role for cell-cell interactions in tumor development.
- Tumorigenesis in NPC is influenced by both systemic and local factors, including immune responses and immunosuppressive mechanisms.
Purpose of the Study:
- To explore the potential of peripheral blood-derived tumor products as biomarkers in nasopharyngeal carcinoma.
- To investigate the role of cellular interactions and immune responses in NPC progression.
- To identify key factors contributing to local immunosuppression in the NPC tumor microenvironment.
Main Methods:
- Analysis of peripheral blood samples from NPC patients.
- Identification and characterization of tumor-derived products, including cytokines, proteins, exosomes, and nucleic acids.
- Investigation of immune cell populations and their interactions within the tumor microenvironment.
Main Results:
- Peripheral blood of NPC patients contains various tumor-derived products with potential biomarker utility.
- Evidence suggests that interactions between stromal and malignant cells, influenced by cytokines like CCL20 and exosomes carrying galectin 9, contribute to tumor development.
- NPC patients exhibit systemic immune responses against EBV-antigens, but local immunosuppression, potentially involving regulatory T-cells, facilitates tumor growth.
Conclusions:
- Tumor-derived products in peripheral blood offer a promising avenue for non-invasive biomarker development in NPC.
- Understanding cellular interactions and immune evasion mechanisms is crucial for developing effective therapeutic strategies against NPC.
- Future therapies may focus on modulating immune tolerance and blocking critical cellular interactions to impede NPC progression.
Related Concept Videos
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...